1. Pulmonary aspergillosis in a Crohn's disease patient receiving adalimumab and steroid therapy.
- Author
-
Ferrer Bradley I, Maroto Arce N, Mora Escrig M, and Hinojosa Del Val J
- Subjects
- Adalimumab therapeutic use, Adrenal Cortex Hormones therapeutic use, Adult, Anti-Inflammatory Agents therapeutic use, Antifungal Agents therapeutic use, Cilastatin therapeutic use, Crohn Disease complications, Diagnosis, Differential, Disease Susceptibility, Humans, Imipenem therapeutic use, Immunocompromised Host, Immunosuppressive Agents therapeutic use, Male, Opportunistic Infections diagnosis, Opportunistic Infections drug therapy, Pulmonary Aspergillosis diagnosis, Pulmonary Aspergillosis drug therapy, Tomography, X-Ray Computed, Tuberculosis, Pulmonary diagnosis, Adalimumab adverse effects, Adrenal Cortex Hormones adverse effects, Anti-Inflammatory Agents adverse effects, Crohn Disease drug therapy, Immunosuppressive Agents adverse effects, Opportunistic Infections etiology, Pulmonary Aspergillosis etiology
- Published
- 2019
- Full Text
- View/download PDF